TARDBP and amyotrophic lateral sclerosis: Lastly, given that TDP-43 inclusions are the pathological hallmarks of FTD/ALS [1,2,7,9,15], it is important to evaluate whether individual B cell clones produce antibodies for immunohistochemistry applications.